Atlas Trials

A Prospective Real-world Study of Cadonilimab in Patients With Recurrent or Metastatic Cervical Cancer

Clinical trial NCT06155422 · NOT_YET_RECRUITING

Trial details

NCT number
NCT06155422
Sponsor
Gang Chen (101199)
Status
NOT_YET_RECRUITING
Study type
OBSERVATIONAL
Recurrent or Metastatic Cervical Cancer
Start date
2023-11-30
Primary completion
2026-11-30
Enrollment
670

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.